208 related articles for article (PubMed ID: 30910217)
1. Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control study.
Liozon E; Delmas C; Dumonteil S; Dumont A; Gondran G; Bezanahary H; Aouba A; Fauchais AL; Ly KH; de Boysson H
Semin Arthritis Rheum; 2019 Oct; 49(2):288-295. PubMed ID: 30910217
[TBL] [Abstract][Full Text] [Related]
2. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
3. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
De Miguel E; Karalilova R; Macchioni P; Ponte C; Conticini E; Cowley S; Tomelleri A; Monti S; Monjo I; Batalov Z; Klinowski G; Falsetti P; Kane DJ; Campochiaro C; Hočevar A
Ann Rheum Dis; 2024 Feb; 83(3):335-341. PubMed ID: 37932008
[TBL] [Abstract][Full Text] [Related]
4. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
[TBL] [Abstract][Full Text] [Related]
5. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
[TBL] [Abstract][Full Text] [Related]
6. Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients.
Hernández-Rodríguez J; Font C; García-Martínez A; Espígol-Frigolé G; Sanmartí R; Cañete JD; Grau JM; Cid MC
Medicine (Baltimore); 2007 Jul; 86(4):233-241. PubMed ID: 17632265
[TBL] [Abstract][Full Text] [Related]
7. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
[TBL] [Abstract][Full Text] [Related]
8. Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center.
Öztaş M; Özgül H; Seyahi E; Uğurlu S
Turk J Med Sci; 2022 Aug; 52(4):917-925. PubMed ID: 36326373
[TBL] [Abstract][Full Text] [Related]
9. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
Pioro MH
Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica.
Narváez J; Estrada P; López-Vives L; Ricse M; Zacarías A; Heredia S; Gómez-Vaquero C; Nolla JM
Semin Arthritis Rheum; 2015 Dec; 45(3):328-33. PubMed ID: 26186807
[TBL] [Abstract][Full Text] [Related]
11. Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.
Kermani TA; Warrington KJ; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; McAlear CA; Monach PA; Seo P; Merkel PA; Ytterberg SR;
J Rheumatol; 2015 Jul; 42(7):1213-7. PubMed ID: 25877501
[TBL] [Abstract][Full Text] [Related]
12. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
13. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
Durkin SR; Athanasiov PA; Crompton JL
Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
[TBL] [Abstract][Full Text] [Related]
14. Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients.
Alba MA; García-Martínez A; Prieto-González S; Tavera-Bahillo I; Corbera-Bellalta M; Planas-Rigol E; Espígol-Frigolé G; Butjosa M; Hernández-Rodríguez J; Cid MC
Medicine (Baltimore); 2014 Jul; 93(5):194-201. PubMed ID: 25181312
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M; Dababneh A; Hajeer A; Ollier WE
J Rheumatol; 1999 Jun; 26(6):1326-32. PubMed ID: 10381051
[TBL] [Abstract][Full Text] [Related]
16. Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis.
Mansalis K
FP Essent; 2016 Jan; 440():16-22. PubMed ID: 26734832
[TBL] [Abstract][Full Text] [Related]
17. The Spectrum of Pericardial Involvement in Giant Cell Arteritis and Polymyalgia Rheumatica: A Systematic Review of Literature.
Fayyaz B; Rehman HJ
J Clin Rheumatol; 2021 Jan; 27(1):5-10. PubMed ID: 31483352
[TBL] [Abstract][Full Text] [Related]
18. Polymyalgia rheumatica and giant cell arteritis.
Unwin B; Williams CM; Gilliland W
Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894
[TBL] [Abstract][Full Text] [Related]
19. Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale.
Gutteridge DH; Mastaglia FL
Intern Med J; 2017 Oct; 47(10):1199-1201. PubMed ID: 28994265
[TBL] [Abstract][Full Text] [Related]
20. Giant cell arteritis and polymyalgia rheumatica: an update.
González-Gay MA; Pina T
Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
